newsfilter
← Latest News
GlobeNewswire·

G1 Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference

RESEARCH TRIANGLE PARK, N.C., Sept. 05, 2023 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (NASDAQ:GTHX), a commercial-stage oncology company, today announced that G1's Communications Officer Will Roberts will provide a